144 related articles for article (PubMed ID: 19562638)
1. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Characteristics and Treatment Efficacy of Children with SIL/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia].
Liu X; Li WJ; Zhao XX; Gao C; Zhao W; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Cui L; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):681-6. PubMed ID: 27342490
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between expression of SIL-TAL1 fusion gene and deletion of 6q in T-cell acute lymphoblastic leukemia].
Wang Q; Wu LL; Dai HP; Ping NN; Wu CX; Pan JL; Cen JN; Qiu HY; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1508-13. PubMed ID: 25543465
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group.
D'Angiò M; Valsecchi MG; Testi AM; Conter V; Nunes V; Parasole R; Colombini A; Santoro N; Varotto S; Caniglia M; Silvestri D; Consarino C; Levati L; Magrin E; Locatelli F; Basso G; Foà R; Biondi A; Cazzaniga G
Haematologica; 2015 Jan; 100(1):e10-3. PubMed ID: 25304610
[No Abstract] [Full Text] [Related]
5. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
[No Abstract] [Full Text] [Related]
6. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
[TBL] [Abstract][Full Text] [Related]
7. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
8. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
[TBL] [Abstract][Full Text] [Related]
10. SIL-TAL1 rearrangement is related with poor outcome: a study from a Chinese institution.
Wang D; Zhu G; Wang N; Zhou X; Yang Y; Zhou S; Xiong J; He J; Jiang L; Li C; Xu D; Huang L; Zhou J
PLoS One; 2013; 8(9):e73865. PubMed ID: 24040098
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features of 19 patients with SIL-TAL1-positive T-cell acute lymphoblastic leukemia].
Wang LJ; Chen Y; Xiang M; Yang XF; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):132-136. PubMed ID: 36948867
[No Abstract] [Full Text] [Related]
12. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R
Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886
[TBL] [Abstract][Full Text] [Related]
14. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract][Full Text] [Related]
15. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
Attarbaschi A; Pisecker M; Inthal A; Mann G; Janousek D; Dworzak M; Pötschger U; Ullmann R; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer R; Strehl S;
Br J Haematol; 2010 Jan; 148(2):293-300. PubMed ID: 19821827
[TBL] [Abstract][Full Text] [Related]
17. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
Curry JD; Smith MT
Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
[TBL] [Abstract][Full Text] [Related]
18. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
19. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.
Chopra A; Soni S; Verma D; Kumar D; Dwivedi R; Vishwanathan A; Vishwakama G; Bakhshi S; Seth R; Gogia A; Kumar L; Kumar R
Asia Pac J Clin Oncol; 2015 Dec; 11(4):293-8. PubMed ID: 26264145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
